Farther Finance Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,347
Closed -$20.7K 5797
2025
Q4
$20.7K Buy
1,347
+75
+6% +$826 ﹤0.01% 3417
2025
Q3
$12.6K Buy
1,272
+17
+1% +$177 ﹤0.01% 3321
2025
Q2
$12.4K Sell
1,255
-7
-0.6% -$74 ﹤0.01% 2965
2025
Q1
$16K Hold
1,262
﹤0.01% 2498
2024
Q4
$16.1K Sell
1,262
-235
-16% -$2.84K ﹤0.01% 2181
2024
Q3
$16.7K Buy
1,497
+7
+0.5% +$77 ﹤0.01% 2165
2024
Q2
$16.6K Hold
1,490
﹤0.01% 1842
2024
Q1
$18.7K Buy
1,490
+1,453
+3,927% +$19K ﹤0.01% 1515
2023
Q4
$517 Buy
+37
New +$514 ﹤0.01% 2965

Other funds holding DVAX

Farther Finance Advisors's DVAX Position: Q1 2026 in Review

Farther Finance Advisors sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,347 shares — an estimated $20.7K sold.

Farther Finance Advisors first reported a position in DVAX in Q4 2023 and held it in 9 quarters. The position peaked at $20.7K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Farther Finance Advisors reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Farther Finance Advisors sold 1,347 Dynavax Technologies shares in Q1 2026, an estimated $20.7K.
  • Farther Finance Advisors first reported a position in Dynavax Technologies in Q4 2023 and held it in 9 quarters.
  • Farther Finance Advisors's Dynavax Technologies position peaked at $20.7K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.